Tudor Investment Corp’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-2,099
Closed -$203K – 1648
2020
Q2
$203K Buy
+2,099
New +$175K 0.01% 1025
2019
Q2
– Sell
-5,000
Closed -$260K – 1442
2019
Q1
$260K Buy
+5,000
New +$230K 0.01% 915
2016
Q4
– Sell
-20,000
Closed -$327K – 1701
2016
Q3
$327K Buy
+20,000
New +$361K 0.01% 972

Other funds holding MYOK

Tudor Investment Corp's MYOK Position: Q3 2020 in Review

Tudor Investment Corp sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 2,099 shares — an estimated $203K sold.

Tudor Investment Corp first reported a position in MYOK in Q3 2016 and held it in 3 quarters. The position peaked at $327K in Q3 2016. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

  • Tudor Investment Corp reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Tudor Investment Corp sold 2,099 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $203K.
  • Tudor Investment Corp first reported a position in MyoKardia, Inc. Common Stock in Q3 2016 and held it in 3 quarters.
  • Tudor Investment Corp's MyoKardia, Inc. Common Stock position peaked at $327K in Q3 2016.
  • 237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on Tudor Investment Corp's 13F filing for Q3 2020, filed 16 Nov 2020.